A comparison of trimethoprim-sulphamethoxazole compound and tetracycline in exacerbations of chronic bronchitis. A double-blind multi-centre trial on in-patients.
D000368:Aged; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001431:Bacteriological Techniques; D001991:Bronchitis / Q000150:complications / Q000188:drug therapy*; D002648:Child; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004357:Drug Synergism; D005260:Female; D005493:Folic Acid Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010919:Placebos; D011247:Pregnancy; D011743:Pyrimidines / Q000008:administration & dosage / Q000627:therapeutic use*; D013183:Sputum / Q000032:analysis; D013420:Sulfamethoxazole / Q000008:administration & dosage / Q000627:therapeutic use*; D013492:Suppuration / Q000188:drug therapy; D013752:Tetracycline / Q000008:administration & dosage / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use
D000890:Anti-Infective Agents; D005493:Folic Acid Antagonists; D010919:Placebos; D011743:Pyrimidines; D014295:Trimethoprim; D013752:Tetracycline; D013420:Sulfamethoxazole